Therapeutic Strategies for Parkinson’s Disease: The Ancient Meets the Future—Traditional Chinese Herbal Medicine, Electroacupuncture, Gene Therapy and Stem Cells

被引：0
作者：
Xuan Wang
Xi-Bin Liang
Feng-Qiao Li
Hui-Fang Zhou
Xian-Yu Liu
Jian-Jun Wang
Xiao-Min Wang
机构：
[1] Capital Medical University,Department of Physiology
[2] Key Laboratory for Neurodegenerative Disorders of the Ministry of Education,Department of Neurology and Neurological Sciences
[3] Stanford University,Division of Neurology
[4] Duke University Medical Center,Department of Anesthesiology
[5] Washington University School of Medicine,Department of Anesthesiology and Basic Medical Science
[6] University of Missouri-Kansas City School of Medicine,Department of Psychiatry
[7] Emory University School of Medicine,Neuroscience Research Institute and Department of Neurobiology
[8] Peking University,undefined
[9] Key Laboratory for Neuroscience of the Ministry of Education,undefined
来源：
Neurochemical Research | 2008年 / 33卷
关键词：
Parkinson’s disease; Triptolide; Electroacupuncture; Gene therapy; Stem cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In China, it has been estimated that there are more than 2.0 million people suffering from Parkinson’s disease, which is currently becoming one of the most common chronic neurodegenerative disorders during recent years. For many years, scientists have struggled to find new therapeutic approaches for this disease. Since 1994, our research group led by Drs. Ji-Sheng Han and Xiao-Min Wang of Neuroscience Research Institute, Peking University has developed several prospective treatment strategies for the disease. These studies cover the traditional Chinese medicine—herbal formula or acupuncture, and modern technologies such as gene therapy or stem cell replacement therapy, and have achieved some original results. It hopes that these data may be beneficial for the research development and for the future clinical utility for treatment of Parkinson’s disease.
引用
收藏
页码：1956 / 1963
页数：7
相关论文
共 379 条
[1]  
Lang AE(1998)Parkinson’s disease. First of two parts N Engl J Med 339 1044-1053
[2]  
Lozano AM(2005)Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai Lancet 365 595-597
[3]  
Zhang ZX(2006)Role of lifestyle factors on plasma homocysteine levels in Parkinson’s disease patients treated with levodopa Nat Neurosci 9 11-16
[4]  
Roman GC(2002)Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson’s disease J Neurochem 81 1285-1297
[5]  
Hong Z(2001)Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F Leuk Lymphoma 42 253-265
[6]  
Wu CB(2003)Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Drugs R&D 4 1-18
[7]  
Qu QM(2000) Hook f. Am J Physiol Lung Cell Mol Physiol 279 L958-L966
[8]  
Huang JB(1999)Anti-inflammatory effects of triptolide in human bronchial epithelial cells J Biol Chem 274 13443-13450
[9]  
Zhou B(2003)Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin–2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation Exp Neurol 179 28-37
[10]  
Geng ZP(2005)Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons Neurobiol Dis 18 441-449
12345678910